PROTECTED DO3A MANUFACTURING
A one-step process for producing DO3A-tri-tert-butyl ester as a hydrobromide salt by reacting 1,4,7,10-tetraazacyclododecane with an activated acetate ester and diluting with water addresses the inefficiencies of existing methods, enabling high-yield, cost-effective industrial production.
Patent Information
- Application Number
- JP2022535505
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-12-13
- Filing Date
- 2020-12-09
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2040-12-09
AI Technical Summary
Existing methods for producing DO3A-tri-tert-butyl ester as a hydrobromide salt are time-consuming and costly, making them unsuitable for large-scale manufacturing.
A one-step process involving the reaction of 1,4,7,10-tetraazacyclododecane with an activated acetate ester in the presence of a base, followed by dilution with water to isolate DO3A-tri-tert-butyl ester as a solid salt, significantly reducing reaction and purification times.
The process allows for the production of DO3A-tri-tert-butyl ester hydrobromide in high yield and purity, eliminating the need for complex purification steps and making it suitable for industrial-scale production.
Smart Images

Figure 0007588645000001 
Figure 0007588645000002 
Figure 0007588645000003
Abstract
Description
[Technical field]
[0001] TECHNICAL FIELD TO WHICH THEINVENTION BELONGS The present invention relates to organic chemistry, and in particular to the preparation of protected DO3A. More particularly, the present invention relates to a one-step method for the preparation and isolation of protected DO3A as a salt, such as DO3A-tri-tert-butyl ester (1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid tri-tert-butyl ester). [Background technology]
[0002] 2. Background of the Invention Magnetic resonance imaging (MRI) is a well-known imaging technique used in clinical diagnosis for many diseases.
[0003] The remarkable development of medical MRI has further benefited from the development of a class of compounds called MRI contrast agents, which act by dramatically altering the proton relaxation rates of nearby water in the tissues / organs / fluids in which they are distributed, adding physiological information relevant to the impressive anatomical resolution obtained in non-contrast MRI images.
[0004] An example of a commercially available MRI contrast agent is a linear chelator, such as a DTPA ligand, and a Gd 3+ Complex compound of ion; Gd with DTPA-BMA ligand sold under the trademark OMNISCAN® 3+ complex; BOPTA's Gd complex, known as gadobenate dimeglumine and sold under the trademark MultiHance®. 3+ and Gd complexes with cyclic chelants such as the DOTA ligand, sold under the trademark DOTAREM®. 3+ The complex compound is a hydroxylated tetraazamacrocyclic ligand known as HPDO3A, which has been sold for many years as ProHance®. 3+ complex, and the corresponding butyltriol derivative known as gadobutrol and sold under the trademark Gadavist®.3+ Complexes are included.
[0005] A key intermediate in the preparation of many of these macrocyclic chelating ligands is DO3A (1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid) and its protected derivatives, such as the tri-tert-butyl ester of the formula: [ka]
[0006] The preparation of DO3A-tri-tert-butyl ester is generally carried out according to two main synthetic routes, with the product being isolated either as the free base or as a salt with the anion of an alkylating agent.
[0007] Isolating the product as the hydrobromide salt has proven to be preferable in large scale production since the product can be recovered in a stable form and conveniently stored for long periods of time without decomposition. If necessary, the hydrobromide salt can be converted to the corresponding free base before use in subsequent reactions.
[0008] Much effort has been expended over time to optimize the synthesis and isolation of DO3A-tri-tert-butyl ester as the hydrobromide salt.
[0009] WO93 / 02045 discloses a method for the tris-alkylation of cyclen with tert-butyl bromoacetate in dimethylacetamide in the presence of NaOAc, which requires a reaction time of 19 days to give the desired hydrobromide salt in an overall yield of 56%.
[0010] A procedure that can shorten the reaction time to 60 hours has been described by Moore in Org. Synth. 2008, 85, 10-14, in which 1,4,7,10-tetraazacyclododecane and NaOAc are reacted with tert-butyl bromoacetate in DMAC, the crude reaction mixture is diluted with diethyl ether and cooled to precipitate the hydrobromide salt of the tri-tert-butyl ester, and then a complex and time-consuming work-up procedure involving multiple cycles of dissolution, washing, and reprecipitation gives the final product in 65-80% yield.
[0011] Jagadish et al. (Tetrahedron Lett., 2011, 52(17), 2058-2061) tris-alkylated 1,4,7,10-tetraazacyclododecane with tert-butyl bromoacetate in DMAC (dimethylacetamide) in the presence of NaOAc at room temperature for 24 hours, poured the reaction mixture into water to obtain a clear solution, and then extracted with KHCO 3 The method discloses a method for precipitating the bromide salt by adding CHCl. The resulting solid is then collected and precipitated with 1,2-dichloromethane. 3 Dissolving in ethyl acetate, washing with water, concentrating, and recrystallizing from ether gives the desired product in about 80% yield.
[0012] US8,138,332 discloses a method for the preparation of 1,4,7,10-tetraazacyclododecane by reacting it with tert-butyl bromoacetate in DMAC (dimethylacetamide) in the presence of NaOAc at room temperature for 5 days, and the reaction slurry is poured into a large excess of water (3.9:1 (w / w) relative to DMAC) to obtain a clear aqueous solution, and solid NaHCO 3 The pH of the solution is adjusted to 9 using a 200 mL hexanes water bath, and a salt such as KBr is added to the solution to precipitate the hydrobromide salt of DO3A-tri-tert-butyl ester. The hydrobromide salt is recovered by filtration, with a yield of approximately 73%.
[0013] The above method was not suitable for mass production because the reaction required several days and purification of the crude product was costly and time-consuming. Summary of the Invention [Problem to be solved by the invention]
[0014] Due to the growing interest in macrocyclic Gd-based contrast agents such as ProHance and Gadobutrol, and more generally in DO3A derivatives, there is a strong need for optimized preparation methods that overcome the above-mentioned drawbacks and allow the convenient production of this important starting material on a larger, e.g. industrial, scale. [Means for solving the problem]
[0015] The applicant has unexpectedly found that it is possible to isolate the DO3A triester directly as a solid salt from the crude reaction product by dilution with water of the reactant obtained by reacting 1,4,7,10-tetraazacyclododecane (or cyclen, as used interchangeably herein) with an activated acetate, such as tert-butyl bromoacetate, in the presence of a base in an organic solvent.
[0016] The present invention relates generally to an improved method for the preparation of protected DO3A, such as DO3A-tri-tert-butyl ester, which is recovered as a solid salt directly from the organic crude reaction mixture diluted with water.
[0017] More particularly, the present invention relates to an optimized process for the preparation of DO3A bearing an ester-protected carbonyl group, which essentially comprises reacting 1,4,7,10-tetraazacyclododecane with an activated acetate ester, e.g., tert-butyl ester, in an organic solvent in the presence of an auxiliary base, diluting the resulting crude mixture with water, and then recovering the triester product as a solid salt directly from the diluted mixture.
[0018] Optionally, the method of preparation comprises adding supplemental water to the organic solvent in which the reagents are miscible.
[0019] One aspect of the present invention is a compound represented by formula (I) [ka] [wherein X is a chlorine, iodine or, preferably, bromine anion; y is an integer from 1 to 3, e.g., 1, 2 or 3; and R is C 1 -C 6 is an alkyl group or an aryl group. The present invention relates to a one-step process for preparing a protected DO3A salt of the formula: 1) Cyclene is reacted with a compound of the formula XCH in the presence of an auxiliary base in an organic solvent. 2 C(O) reacting with an activated acetate ester, designated OR, to give a crude reaction mixture; 2) adding water to the crude mixture of step 1) to obtain a suspension containing the protected DO3A in the form of a solid salt of formula (I); and 3) The protected DO3A salt is recovered and washed.
[0020] The organic solvent used in the reaction of step 1) is preferably a dipolar aprotic solvent such as DMF, DMSO, MeCN, DMAC, etc. More preferably, the organic solvent is DMAC. The auxiliary base is preferably NaOAc, NaHCO 3 , Na 2 CO 3 , K.H.C.O. 3 , K 2 CO 3 , DIPEA, triethylamine and the like, more preferably NaOAc.
[0021] Preferably, in the above formula (I), X is bromine, y is 1 or 2, more preferably, y is 1. In one embodiment, in the above formula (I), R is benzyl, more preferably, R is C 1 -C 6 It is an alkyl.
[0022] C in the present invention 1 -C 6Alkyl includes straight or branched chains of 1 to 6 carbon atoms, such as methyl, ethyl, propyl, iso-propyl, butyl, iso-butyl, tert-butyl, pentyl, hexyl, etc. Most preferably, in formula (I), R is tert-butyl.
[0023] In certain embodiments, the reaction mixture of step 1 further comprises water.
[0024] In a preferred embodiment, step 1) of the process comprises reacting 1,4,7,10-tetraazacyclododecane with tert-butyl bromoacetate to prepare DO3A protected as a tri-tert-butyl ester, e.g. DO3A-tri-tert-butyl ester monohydrobromide.
[0025] Advantageously, the process of the present invention allows the recovery of DO3A-tri-tert-butyl ester as the hydrobromide salt in good yield and optimal purity directly from the crude reaction mixture, and therefore can be used as is (or conveniently stored) without the need for further complex and time-consuming purification or recrystallization. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0026] Detailed Description of the Invention In one embodiment, the present invention provides a compound of formula (IA) [ka] [In the formula, y is an integer of 1 to 3, preferably 1 to 2, and more preferably 1] The present invention relates to a one-step process for the preparation of a salt of DO3A-tri-tert-butyl ester, which comprises: 1) reacting cyclen with tert-butyl bromoacetate in an organic solvent in the presence of an auxiliary base to obtain a mixture; 2) adding water to the mixture of step 1) to obtain a suspension containing DO3A-tri-tert-butyl ester of formula (IA) as a solid salt; and 3) Recover and wash the salt of DO3A-tri-tert-butyl ester The present invention comprises the steps of:
[0027] Step 1 Step 1) of the process comprises reacting cyclen with tert-butyl bromoacetate as shown in synthetic scheme 1 below. [ka]
[0028] This step generally comprises adding tert-butyl bromoacetate to cyclen in an organic solvent in the presence of an auxiliary base to obtain a mixture containing DO3A-tri-tert-butyl ester as a solid salt.
[0029] For example, cyclen and auxiliary base are first combined in an organic solvent to form a mixture, and then tert-butyl bromoacetate is added.
[0030] In one embodiment, the tert-butyl bromoacetate is added neat to the mixture without prior dilution.
[0031] In a preferred embodiment, step 1) of the process of the present invention comprises: i) obtaining a solution of tert-butyl bromoacetate in an organic solvent, and ii) adding the obtained solution to a mixture of cyclen and auxiliary base in the same organic solvent. Suitable organic solvents include the dipolar aprotic solvents described above; in a preferred embodiment, the organic solvent for use in the process of the invention is DMAC.
[0032] For example, tert-butyl bromoacetate is first diluted with DMAC, for example at room temperature, to give a tert-butyl bromoacetate solution having a concentration of preferably 3 to 7 mol / L (here, L refers to DMAC), more preferably 3 to 5 mol / L, and most preferably about 4 to 5 mol / L.
[0033] The resulting solution is then added to a mixture of cyclen and auxiliary base in DMAC. Preferably, the auxiliary base in the mixture is a weak base; in a preferred embodiment, it is NaOAc. More typically, the mixture is a suspension.
[0034] In some embodiments, the mixture of cyclen and auxiliary base in DMAC in step 1) may further contain a certain amount of water (or dilution water).
[0035] When present, the amount of dilution water is from 0.1 to 2 times (by weight) the amount of cyclene in the mixture, more preferably from 0.5 to 1.5 times, and more preferably an amount substantially equal to the weight of cyclene.
[0036] The process preferably comprises preparing a suspension of cyclen and NaOAc in DMAC (and optionally water) such that the final concentration of cyclen is 0.5-1.0, preferably 0.6-1.0, most preferably 0.6-0.85 mol / L. The amount of tert-butyl bromoacetate then added to the suspension is sufficient to effect the desired trialkylation of cyclen while avoiding undesired further alkylation.
[0037] In one embodiment, the alkylation reaction of step 1) is carried out using a substantially stoichiometric ratio of cyclen: tert-butyl bromoacetate of 1:3 (mol / mol). In another embodiment, an excess of tert-butyl bromoacetate, for example about 1-30%, preferably 1-10%, may be used, corresponding to a cyclen: tert-butyl bromoacetate ratio of 1:3 to 1:4 (mol / mol). Similarly, in one embodiment, a substantially stoichiometric ratio of cyclen to the weak base NaOAc of 1:3 may be used, and in another embodiment, an excess of base in the range of 1-30%, preferably 1-10%, relative to the stoichiometric amount may be used.
[0038] It is preferable to add an appropriate amount of tert-butyl bromoacetate solution to the obtained suspension of cyclen and NaOAc while maintaining the temperature at 0 to 25° C. under stirring.
[0039] The addition is conveniently carried out over a period of from 1 to 4 hours, preferably from 2 to 3 hours.
[0040] After the addition, the reaction mixture is maintained under stirring until the alkylation reaction is complete, for example, for about 16 to 48 hours.
[0041] In one embodiment, the addition of tert-butyl bromoacetate and completion of the reaction are carried out at the same temperature, e.g., 0-25°C, preferably 5-15°C, more preferably 10-15°C, e.g., about 12°C, and the resulting reaction mixture is then warmed to (or maintained at) 25°C and stirred at this temperature for about 2-4 hours.
[0042] In another embodiment, the addition of tert-butyl bromoacetate is carried out at a lower temperature, preferably between 0-15°C, and the completion of the alkylation reaction is carried out at a higher temperature, preferably between 20-35°C.
[0043] For example, in one embodiment, step 1) of the process comprises adding a solution of tert-butyl bromoacetate in DMAC at a temperature of about 10° C. to a suspension of cyclen and NaOAc in the same solvent (and optionally water) for a period of about 2.5 hours, during which the temperature of the reaction mixture is maintained at 10-15° C. The resulting reaction mixture is then maintained at this temperature with stirring until alkylation is complete, for example for 20-48 hours, preferably for 20-30 hours, more preferably for 20-25 hours. After completion, the temperature of the reaction mixture is preferably increased to room temperature (e.g., about 25° C.) and the mixture is maintained at this temperature with stirring for an additional 2-4 hours.
[0044] In another embodiment, after the addition of the tert-butyl bromoacetate solution, the temperature of the resulting reaction mixture is raised, for example to 23-35° C., and the mixture is maintained at this temperature with stirring until the alkylation is complete. Preferably, the reaction mixture is left under stirring at a temperature of 25-30° C. for 20-30 hours, preferably 20-25 hours.
[0045] Under the above conditions, selective trialkylation of cyclen is obtained, forming DO3A-tri-tert-butyl ester in suspension as a solid salt, for example as a mixture of hydrobromide salts, more typically as the monohydrobromide salt.
[0046] A crude mixture, typically a suspension or slurry, is thus obtained, comprising, in the solid suspended phase, the DO3A-tri-tert-butyl salt (e.g. as the hydrobromide salt), by-product salts (e.g. NaBr), and possibly traces of unreacted base and / or organic impurities.
[0047] Step 2 Step 2) is conveniently carried out by adding water (also referred to herein as "work-up water") to the raw material slurry obtained in step 1).
[0048] The Applicant has surprisingly found that by suitable addition of water to the slurry recovered in step 1) of the present process, it is indeed possible to solubilize the by-products and unreacted components while leaving and recovering the salt of DO3A-tri-tert-butyl ester (hydrobromide salt) as essentially the only solid in the resulting crude suspension.
[0049] The amount (weight) of water to be added to the crude mixture recovered from step 1) can be appropriately determined, for example, based on the amount (weight) of cyclen to be subjected to the alkylation reaction.
[0050] A suitable amount (by weight) of work-up water may be, for example, up to 10 times the amount of starting cyclen subjected to the alkylation reaction. Such amount of work-up water is generally independent of the presence of any amount of water in the initial reaction mixture comprising cyclen and auxiliary base in DMAC, provided that such any amount does not exceed twice the amount of cyclen.
[0051] In a preferred embodiment, step 2) of the process is carried out by diluting the feed slurry obtained in step 1) with work-up water in an amount preferably greater than 2 times (e.g. about 2.5 times) the amount (w / w) of the cyclene undergoing the alkylation reaction. Preferably, the amount of water is 3-10 times, more preferably 3-8 times, most preferably 3-6 times, particularly preferably 4-6 times, e.g. about 4 times, about 5 times or about 6 times, by weight, of the amount (w / w) of cyclene in the reaction.
[0052] In fact, as confirmed by the experimental results, diluting the crude suspension obtained in step 1) with more than two times the amount of water (e.g., an amount equivalent to 2.5-8 times, preferably 3-8 times, the amount (by weight) of the starting material cyclen (subjected to trialkylation)) can solubilize most of the undesired salts / impurities in the suspension while avoiding the loss of the desired product, thus obtaining the desired product in good yield and purity.
[0053] Dilution is typically performed with purified water (eg, water purified by Milli-Q or reverse osmosis membrane) at 15-20°C.
[0054] Preferably, the dilution is carried out at a temperature of 20-25° C., more preferably about 20° C., for a period of about 0.5-1 hour, more preferably about 0.5 hour.
[0055] In a particularly preferred embodiment, step 2) of the present process comprises diluting the suspension recovered in step 1) with a certain amount of the above-mentioned purified water (preferably 3 to 8 times, more preferably 3 to 6 times, and most preferably 4 to 6 times the amount (by weight) of the starting cyclen) at a temperature of 20 to 25°C for about 30 minutes, and then maintaining the crude mixture at about 20°C with stirring for 0.5 to 3 hours, preferably for about 2 hours.
[0056] A suspension is thus obtained, in which the solid phase consists essentially of the hydrobromide salt of DO3A-tri-tert-butyl ester and, optionally, traces of residual undesired reaction salts. The total amount of water in the suspension (i.e. including the water added in step 2) and optionally the water of step 1) is at least 2.5 times, more preferably at least 3 times, even more preferably at least 4 times, the amount (w / w) of cyclen added in step 1) and at most 10 times, preferably at most 8 times, the amount of cyclen.
[0057] Step 3 Step 3) of the process involves recovering and washing the solid product present in the suspension obtained in step 2. The solid can be conveniently recovered using procedures known to those skilled in the art.
[0058] In one embodiment, the solids are recovered by filtration of the crude suspension.
[0059] In another embodiment, which is particularly preferred when carried out on an industrial scale, the suspension obtained in step 2) of the process is centrifuged to remove residual amounts of DMAC in the liquid phase, water, solubilized reaction salts and optionally liquid impurities, to obtain a wet solid containing the crude product as a solid salt, and then the solid salt is recovered.
[0060] Centrifugation is usually carried out at high speed (eg, 1800 to 2500 rpm).
[0061] The recovered cake containing the crude product is then washed.
[0062] Preferably, the recovered crude product is washed with water (ie, the "wash water").
[0063] In one preferred embodiment, the recovered wet solid containing the crude product is washed with water in an amount of 4 to 20 times the weight of the cyclen used in the reaction.
[0064] In this case, the appropriate amount of water capable of dissolving and removing the residual salts / impurities is preferably determined relative to the amount of water added to the raw slurry in step 2) of the present process.
[0065] Indeed, it is clear to the skilled person that a smaller dilution of the feed mixture in step 2) is preferably associated with washing the crude product from step 3) with a larger amount of water. Conversely, a larger dilution of the feed mixture with more water allows to use a smaller amount of washing water.
[0066] For example, as confirmed by the experimental results, when the raw slurry obtained in step 1) of the present process is diluted with work-up water in an amount (w / w) of about 8 times the amount (weight) of the starting cyclen, the crude recovered in step 3) can be properly washed twice with washing water in an amount equivalent to 2-8 times, more preferably 2-4 times the weight of the cyclen, and still obtain the product with optimal purity.
[0067] Alternatively, if the feed slurry is diluted with a low amount of workup water, e.g., about 3-4 times the weight of the cyclen, the recovered crude is preferably washed twice with a high amount of water, e.g., 4-10 times, more preferably 4-8 times the weight of the starting cyclen.
[0068] In a preferred embodiment, the raw slurry obtained in step 1) of the present process is diluted with water in an amount of about 4 times the amount (weight) of the cyclen to obtain a crude product, which is then washed twice with water in an amount of about 4 times the amount (weight) of the cyclen, in which the ratio of the total amount of organic solvent:water corresponds to about 1:1 to 1:1.1 (w / w).
[0069] After washing, the product is recovered, for example, by filtration or centrifugation of the solids, and the wet product is then dried, for example at or above room temperature (rt) and / or under reduced pressure.
[0070] In one preferred embodiment, the product is dried at a temperature of 35-40° C. and reduced pressure (e.g., 5-25 mbar) for 20-25 hours to give DO3A-tri-tert-butyl ester as monohydrobromide salt in 73-83% yield.
[0071] While the above description refers specifically to the preparation of DO3A-tri-tert-butyl ester hydrobromide, i.e., a compound of formula (I) where X is a bromide anion and R is tert-butyl, one skilled in the art will appreciate that the disclosed process also applies to the preparation of compounds of formula (I) where X is a chloride, fluorine or iodide anion, y is 2 or 3 and R is benzyl or a C anion other than, preferably, tert-butyl. 1 -C 6 It will be appreciated that the preparation of a compound in which the aryl group is an alkyl group can be carried out in a similar manner. [ka]
[0072] Advantageously, use of the process of the present invention allows for significant reductions in both reaction times and work-up times.
[0073] For example, the process of the present invention is capable of obtaining the desired product in a yield of about 83%, or even higher when carried out on an industrial scale, in a reaction time of about 24 hours, which is significantly shorter than the reaction time required by known processes.
[0074] More specifically, the presented process makes it possible to obtain DO3A-tri-tert-butyl ester directly as hydrobromide salt from the crude reaction mixture (obtained by reacting 1,4,7,10-tetraazacyclododecane with tert-butyl bromoacetate in an organic solvent such as DMAC and in the presence of a weak base such as NaOAc) in the above-mentioned yields and with a purity of at least 95%, preferably at least 97%, more preferably at least 98%, most preferably at least 99%, for example up to 99.5%, simply by diluting the crude reaction mixture with water, recovering the solid hydrobromide salt and washing it with water; thus, the recovered product can advantageously be used as it is without the need for expensive and / or time-consuming further purification or reprecipitation or recrystallization steps, making the process particularly advantageous for large-scale production, for example industrial production.
[0075] The purity of the recovered hydrobromide salt can be determined by a variety of analytical methods, such as, for example, NMR versus standards to confirm and analyze the structure of the recovered compound, HPLC to measure purity, and to determine the presence of residual NaBr by titration.
[0076] In another aspect, the present invention provides a compound represented by formula (II) [ka] [In the formula, R 1 and R 2 Both are -CH 2 OH or R 1 is H and R 2Ga-CH 3 is] or Fe 2+ , Fe 3+ , Cu 2+ , Cr 3+ , Gd 3+ ,EU 3+ , Dy 3+ , La 3+ , Yb 3+ Or Mn 2+ or a chelate complex thereof with a paramagnetic metal ion selected from the group consisting of alkaline earth metal ions, or a salt thereof, which comprises: a) preparing the hydrobromide salt of DO3A-tri-tert-butyl ester according to the synthesis method described above; b) converting the resulting hydrobromide salt into the desired ligand of formula (II); and c) optionally complexing the resulting ligand with a metal ion and isolating the complex.
[0077] Preferably, the paramagnetic metal ion is Gd 3+ and the alkaline earth metal ion is Ca 2+ and the chelate complex prepared is gadobutrol, gadoteridol or carteridol.
[0078] More preferably, the metal ion is Gd 3+ and the chelate complex prepared is gadoteridol or gadobutrol of the formula: [ka]
[0079] More particularly, in a further aspect, the present invention relates to a novel process for the synthesis of gadoteridol or gadobutrol comprising: a) preparing DO3A-tri-tert-butyl ester as the hydrobromide salt according to the process of the present invention; b) converting the resulting hydrobromide salt into the desired ligand of formula (II); and c) The resulting ligand was converted to Gd 3+ Complexing with metal ions and isolating the gadoteridol or gadobutrol complexes, respectively.
[0080] In the above process, step a) comprising the preparation of DO3A-tri-tert-butyl ester as the hydrobromide salt is carried out according to the process of the present invention as described in detail above, and steps b) and c) are carried out according to procedures well known in the art, including the experimental conditions and any variations thereof.
[0081] For example, step b) may comprise: i) neutralizing the recovered hydrobromide salt and deprotecting it to obtain the DO3A ligand in the acid form with the carboxyl group deprotected; and ii) alkylating DO3A to achieve the desired ligand in the acid form.
[0082] Neutralization of the hydrobromide salt recovered from step a) and removal of the protecting groups can be carried out according to known techniques (e.g. hydrolysis in the presence of a base or treatment with trifluoroacetic acid). Alkylation of the resulting DO3A can then be carried out, for example, as follows: Using a suitable epoxide, for example as disclosed in EP0988294, the desired 10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid (HPDO3A) or [10-[2,3-dihydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid (butyltriol of DO3A) ligand can be obtained.
[0083] Alternatively, the ligand of formula (II) can be prepared by alkylation in the presence of a base of the hydrobromide salt recovered from step a) or of the DO3A-tri-tert-butyl ester recovered after neutralization of the salt carried out in a separate step. The alkylation reaction can be carried out according to conventional procedures, such as, for example, reaction of an ester with an optionally protected alkylating group or with an epoxide, as shown diagrammatically in Scheme 1 below. [ka]
[0084] The resulting alkylated ester is then deprotected according to conventional techniques, for example by use of trifluoroacetic acid, to yield the deprotected ligand.
[0085] Step c) of the process, which involves the complexation of the ligand obtained in step b) with gadolinium, can for example be carried out by stoichiometrically adding to a solution of the ligand a suitable Gd(III) derivative, in particular a Gd(III) salt or oxide, according to well-known experimental methods, for example as described in EP 230893.
[0086] In a further embodiment, the present invention relates to a novel process, wherein the hydrobromide salt of DO3A-tri-tert-butyl ester obtained according to the process of the present invention is used as starting material for the preparation of compounds disclosed in WO2017 / 098038, WO2017 / 098044 or WO2018 / 108780.
[0087] All starting materials, including solvents, and auxiliary reactants such as NaOAc or other bases used in the processes of the present invention are commercially available.
[0088] Further details regarding the process of the present invention are provided in the experimental section below as a general reference to the operating conditions used in the process of the present invention.
[0089] Experimental Part Abbreviations and definitions TIFF0007588645000009.tif185144
[0090] HPLC Assay of DO3A-Tri-tert-butyl-HBr General Procedure HPLC characterization of recovered DO3A-tri-tert-butyl ester hydrobromide The HPLC characterization of DO3A-tri-tert-butyl ester hydrobromide obtained by the process of the present invention was carried out using a liquid chromatograph Agilent 1100 system. The experimental setup for the HPLC measurement is summarized below. Analysis conditions TIFF0007588645000010.tif159138
[0091] Measurement of DO3A-tri-tert-butyl-HBr bromide assay General Procedure The bromide ion content in the recovered DO3A-tri-t-butyl HBr is determined by potentiometric titration using a Ag / AgCl composite electrode and a 0.1N silver nitrate solution according to known procedures. EXAMPLES
[0092] Example 1: Synthesis of DO3A-tri-tert-butyl ester monohydrobromide: Cyclene the starting material with workup water 4x and wash water 2 (4x) (w / w) The synthesis is carried out according to the following synthetic scheme. [ka] To a suspension of commercially available 1,4,7,10-tetraazacyclododecane (15.1 kg; 87.65 mol; conc. = 0.83 mol / L (DMAC)) and sodium acetate (22.65 kg; 276.11 mol) in DMAC (99 kg; 105.3 L) was added tert-butyl bromoacetate (53.87 kg; 276.11 mol; conc. = 4.88 mol / L (DMAC)) in DMAC (53.23 kg; 56.63 L) at 10 °C over 2.5 h. The temperature was then raised to 25 °C and the mixture was stirred for 24 h. Water (60.0 kg; ratio of starting material to cyclen 4:1 w / w) was then added over a period of 0.5 h. After 2 hours, the mixture was centrifuged and the collected cake was washed with water (2x 60.0 Kg = 2x starting material to cyclen ratio 4:1 w / w). The wet solid was dried under vacuum to give 38.43 kg of the desired hydrobromide salt as a white powder. Yield: 73.5% Title HPLC: 100% (against standard) NMR of the title: 99.86% (against the standard) Bromine Assay: 100.7%
[0093] Example 2: Synthesis of DO3A-tri-tert-butyl ester hydrobromide For the starting material cycle, work-up water 4x and wash water 5.3x + 4x (w / w) Cyclene (9 kg; 52.24 mol; 0.83 mol / L) and sodium acetate (13.5 kg; 164.57 mol) in DMAC (59.3 kg; 63.1 L) were charged to the reactor. The resulting suspension was maintained under stirring at 25° C. for 30 minutes. The suspension was then cooled to 10° C. and a solution of tert-butyl bromoacetate (32.1 kg; 164.57 mol; 4.85 mol / L) in DMAC (31.9 kg; 33.9 L) was added during 3 hours. The pipeline was then washed with DMAC (2.15 kg; 2.29 L) before being added to the reaction mixture. The temperature was then increased to 25° C. and the mixture was stirred for 24 hours. Water (36.1 kg; starting material to cyclen ratio 4:1 w / w) was then added during 0.5 h, and after 2 h the mixture was centrifuged and the cake washed with water (47.4 kg + 36.5 kg). The wet solid was dried under vacuum to give 22.70 kg of hydrobromide salt. Yield: 72.8%. Title HPLC: 100% (against standard) NMR of the title: 99.86% (against the standard) Bromine Assay: 100.6%
[0094] Example 3: Synthesis of DO3A-tri-tert-butyl ester hydrobromide Cyclene the starting material with workup water 4x and wash water 2 (4x) (w / w) Cyclene (9 kg; 52.24 mol; 0.83 mol / L) and sodium acetate (13.5 kg; 164.57 mol) in DMAC (59.15 kg; 62.93 L) were charged into the reactor. The resulting suspension was maintained under stirring at 25 °C for 30 minutes. The suspension was then cooled to 10 °C and a solution of tert-butyl bromoacetate (32.14 kg; 164.74 mol; 4.86 mol / L) in DMAC (31.85 kg; 33.88 L) was added during 3 hours. The pipeline was washed with DMAC (2.15 kg; 2.29 L) and then added to the reaction mixture. The temperature was then increased to 25 °C and the mixture was stirred for 24 hours. Water (36 kg) was then added during 0.5 hours and after 2 hours the mixture was centrifuged and the cake was washed with water (36.7 kg + 36.8 kg). The damp solid was dried under vacuum to give 24.16 kg of the hydrobromide salt. Yield: 76.7%. Title HPLC: 100% (against standard) NMR of the title: 98.84% (against standard) Bromine Assay: 99.9%
[0095] Example 4: Synthesis of DO3A-tri-tert-butyl ester hydrobromide For the starting material cycle, work-up water 4x (w / w) and wash water 2 (4x) (w / w) Cyclene (10.0 g; 58.05 mmol) and sodium acetate (17.9 g; 217.68 mmol) in DMAC (72.5 mL) were charged into the reactor. The resulting suspension was maintained under stirring (250 rpm) at 25 °C for 30 min. The suspension was then cooled at 12 °C and a solution of tert-butyl bromoacetate (42.5 g; 217.68 mmol) in DMAC (37.5 mL) was added over 1.5 h at 12 °C. The mixture was stirred at this temperature for 24 h, then heated to 25 °C and stirred at this temperature for 2 h. After cooling at about 18-20 °C, water (40 mL) was added during 0.25 h and after 1 h the mixture was filtered through a porous septum P3 and washed with water (40 mL + 40 mL). The wet solid was dried under vacuum. Yield: 82.9% HPLC area%:99.2% Title NMR (against standard): 97.6% Bromine Assay: 102.0%
[0096] Example 5: Synthesis of DO3A-tri-tert-butyl ester hydrobromide For the starting cyclen, dilution water 1x, work-up water 8x and wash water 2x (w / w) Cyclene (10.0 g; 58.05 mmol) and sodium acetate (17.9 g; 217.68 mmol) in DMAC (72.5 mL) were charged to the reactor. The resulting suspension was maintained at 25 °C under stirring (250 rpm) for 30 min. The suspension was then cooled at 12 °C and water (10 mL) was added. A solution of tert-butyl bromoacetate (42.5 g; 217.68 mmol) in DMAC (37.5 mL) was added over 2.25 h while maintaining the temperature at 12 °C. The mixture was stirred at this temperature for 24 h and then heated to 25 °C and stirred at this temperature for 2 h. After cooling at about 18-20 °C, water (80 mL) was added during 0.5 h and after 1 h the mixture was filtered through a porous septum P3 and washed with water (20 mL + 20 mL). The wet solid was dried under vacuum. Yield: 80.4% HPLC area%:98.1% Title NMR (against standard): 97.7% Bromine Assay: 103.6%
[0097] Example 6: Synthesis of DO3A-tri-tert-butyl ester hydrobromide For the starting cyclen, dilution water 1x, work-up water 8x and wash water 2x (w / w) Cyclene (10.0 g; 58.05 mmol) and sodium acetate (16.7 g; 203.17 mmol) in DMAC (72.5 mL) were charged to the reactor. The resulting suspension was maintained at 25 °C under stirring (250 rpm) for 30 min. The suspension was then cooled at 0 °C and water (10 mL) was added. A solution of tert-butyl bromoacetate (39.6 g; 203.17 mmol) in DMAC (37.5 mL) was added over 2.25 h while maintaining the temperature at 0 °C. The mixture was stirred at this temperature for 24 h and then heated to 25 °C and stirred at this temperature for 2 h. After cooling at about 18-20 °C, water (80 mL) was added during 0.5 h and after 1 h the mixture was filtered through a porous septum P3 and washed with water (20 mL + 20 mL). The wet solid was dried under vacuum. Yield: 77.3% HPLC area%:98.3% Title NMR (against standard): 97.5% Bromine Assay: 106.9%
[0098] Example 7: Synthesis of DO3A-tri-tert-butyl ester hydrobromide For the starting material cycle, work-up water 2x and wash water 2 (2x) (w / w) Cyclene (10.0 g; 58.05 mmol) and sodium acetate (15.0 g; 182.85 mmol) in DMAC (72.5 mL) were charged into the reactor. The resulting suspension was maintained at 25 °C under stirring (250 rpm) for 30 min. The suspension was then cooled at 10 °C and a solution of tert-butyl bromoacetate (35.7 g; 182.85 mmol) in DMAC (38.0 mL) was added at 11 °C over 2.5 h. The temperature was then raised to 25 °C over the course of 1 h and the mixture was stirred at this temperature for 24 h. After cooling at about 18-20 °C, water (20 mL) was added over 0.5 h and after 2 h the mixture was filtered through a porous septum P3 and washed with water (20 mL + 20 mL). The wet solid was dried under vacuum. Yield: 72.6% HPLC area%:99.0% Title NMR (against standard): 95.9% Bromine Assay: 104.3%
[0099] Example 8: Evaluation of the effect of water volume To determine the appropriate amount of water to add to the crude slurry obtained by the reaction of 1,4,7,10-tetraazacyclododecane with tert-butyl bromoacetate in DMAC and NaOAc, tests were performed using 10 g of starting cyclen, the same amount of DMAC (110 ml total) and tert-butyl bromoacetate, a fixed ratio of tert-butyl bromoacetate:cyclen, and varying amounts of workup / wash water.
[0100] Cyclene (10.0 g; 58.05 mmol) and sodium acetate (15.0 g; 182.85 mmol) in DMAC (72.5 mL) were placed in a reactor. The resulting suspension was maintained at 25 °C under stirring (250 rpm) for 30 min. The suspension was then cooled at 10 °C and a solution of tert-butyl bromoacetate (35.7 g; 182.85 mmol) in DMAC (37.5 mL) was added at 10 °C over 2.5 h. The temperature was then raised to 25 °C over the course of 1 h and the mixture was stirred at this temperature for 24 h. After cooling at about 18-20 °C, a given amount of water (see table below) was added over the course of 0.5 h and after 2 h the mixture was filtered through a porous septum P3 and washed with water. The wet solid was dried under vacuum. The results of various tests carried out using various amounts of work-up water and wash water (amounts of water are given as parts by weight relative to the amount of starting cyclen) are shown in Table 1 below (purity of recovered product is given as HPLC (area %) and title NMR (vs. standard). [Table 1]
[0101] result Although these were obtained from tests carried out on a laboratory scale (resulting in less efficient washing and filtration compared to pilot or industrial plants), the results shown in the above table confirm that the specified operating conditions allow the isolation of the desired product in good yield and with an optimum purity of more than 95%, which can be used as is without the need for further work-up or purification.
Claims
1. Formula (I) 【Chemistry 1】 [In the formula, X is a chloride, iodine or bromide anion; y is an integer from 1 to 3; R is C 1 -C 6 Alkyl or aryl groups is] A one-step process for the preparation of a protected DO3A salt of 1) Cyclene is reacted with a compound of formula XCH in the presence of an auxiliary base in an organic solvent. 2 with an activated acetate ester represented by C(O)OR to obtain a mixture; 2) adding water to the mixture of step 1) to obtain a suspension comprising the protected DO3A of formula (I) as a solid salt; and 3) Recover and wash the protected DO3A salt. A method of manufacturing comprising:
2. 2. The process of claim 1, wherein the mixture of step 1) further comprises water.
3. The process according to claim 2, wherein the amount of water in the mixture of step 1) is 0.1 to 2 times (w / w) the amount of cyclen.
4. The process according to any one of claims 1 to 3, wherein in formula (I), X is bromine and R is tert-butyl.
5. The process according to any one of claims 1 to 4, wherein in step 1), the organic solvent is DMAC and the auxiliary base is NaOAc.
6. 6. The process of claim 5, wherein the reaction of step 1) is carried out at a cyclen:tert-butyl bromoacetate ratio and cyclen:NaOAc ratio of 1:3 to 1:4 (mol / mol).
7. 7. The process of claim 6, wherein the ratio of cyclen:tert-butyl bromoacetate and cyclen:NaOAc is from 1:3 to 1:3.
3.
8. Step 1) i) obtaining a solution of tert-butyl bromoacetate in DMAC; ii) adding the resulting solution to a suspension of cyclen and NaOAc in DMAC; The method according to any one of claims 5 to 7, comprising:
9. The method according to claim 8, wherein the concentration of tert-butyl bromoacetate in the solution is 3 to 5 mol / L and the concentration of cyclen in the suspension is 0.5 to 1.0 mol / L.
10. A process according to any of claims 8 to 9, wherein the solution of tert-butyl bromoacetate is added to a stirred suspension of cyclen and NaOAc at a temperature between 0 and 25°C.
11. 11. The process of claim 10, wherein the suspension of cyclen and NaOAc in DMAC is stirred at a temperature between 0 and 15°C.
12. The method according to any one of claims 1 to 11, wherein the amount of water added in step 2) is 2.5 to 10 times (w / w) the amount of cyclen in step 1).
13. The process according to any one of claims 1 to 12, wherein step 3) comprises recovering the protected DO3A salt of formula (I) obtained in step 2) and washing the recovered salt with water.
14. 14. The process of claim 13, wherein the protected DO3A salt is recovered by filtration or centrifugation.
15. The process according to claim 13 or 14, wherein the amount of washing water is 4 to 20 times (w / w) the amount of cyclen in step 1).
16. The process according to any one of claims 1 to 15, wherein the recovered protected DO3A salt is DO3A-tri-tert-butyl ester monohydrobromide.
17. 17. The process of claim 16, wherein the DO3A-tri-tert-butyl ester monohydrobromide has a purity of at least 95%.
Citation Information
Patent Citations
Synthesis of cyclen derivatives
JP2008538371A
Metal Complexes of Tetraazamacrocyclic Derivatives
JP2009534299A
Self-assembling molecules that accumulate in acidic tumor microenvironments
WO2016022987A1
Novel process for the preparation of macrocyclic chelant 2,2',2''-(10-(2-hydroxypropyl)-1,4,7,10-tetra azacyclododecane-1,4,7-triyl) triacetic acid and it's complexes with paramagnetic metal ions
WO2020084504A1
